Butanoic acid,2-methyl-,5-(acetyloxy)-6,7-bis(benzoyloxy)octahydro-4-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester (9CI) (126770-34-1)

Identification
Name:	Butanoic acid,2-methyl-,5-(acetyloxy)-6,7-bis(benzoyloxy)octahydro-4-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester (9CI)
Synonyms:	2H-3,9a-Methano-1-benzoxepin,butanoic acid deriv.; (-)-Celaglaumin; Celaglaumin
CAS:	126770-34-1
Molecular Formula:	C36H44 O10
Molecular Structure:
Properties
Safety Data

Other Product

Butanoic acid,2-methyl-,10-(acetyloxy)-5,6-bis(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-4-ylester (9CI)
3-Furancarboxylic acid,10-(acetyloxy)-5a-[(acetyloxy)methyl]octahydro-9-hydroxy-2,2,9-trimethyl-6,7-bis(2-methyl-1-oxobutoxy)-2H-3,9a-methano-1-benzoxepin-5-ylester (9CI)
Butanoic acid,2-methyl-,10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6,7-diylester (9CI)
Butanoic acid,2-methyl-,6-(acetyloxy)octahydro-2,2,5a,9-tetramethyl-5-[(1-oxo-3-phenyl-2-propenyl)oxy]-2H-3,9a-methano-1-benzoxepin-7-ylester (9CI)
2-Propenoic acid,3-phenyl-,(3R,5S,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-4-oxo-2H-3,9a-methano-1-benzoxepin-6-ylester
2-Propenoic acid,3-phenyl-,6,10-bis(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-4-ylester, (3R,4R,5S,5aS,6S,9S,9aS,10R)- (9CI)
Propanoic acid,2-methyl-,(3R,5S,5aR,6R,7S,9R,9aS)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-7-ylester (9CI)
3-Pyridinecarboxylicacid,(3R,4R,5S,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-6-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]-2H-3,9a-methano-1-benzoxepin-4-ylester
3-Pyridinecarboxylicacid,(3R,4R,5S,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-6-[[(2Z)-1-oxo-3-phenyl-2-propen-1-yl]oxy]-2H-3,9a-methano-1-benzoxepin-4-ylester
2-Propenoic acid,3-phenyl-,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester, (2E)-
2-Propenoic acid,3-phenyl-,(3R,4R,5S,5aS,6S,9S,9aS,10R)-4,10-bis(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6-ylester
2-Propenoic acid,3-phenyl-,(3R,5S,5aR,6R,7S,9S,9aS,10R)-7,10-bis(acetyloxy)-5-(benzoyloxy)octahydro-9-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-6-ylester, (2E)- (9CI)
2-Propenoic acid,3-phenyl-,(3R,5S,5aR,6R,7S,9R,9aS)-6-(acetyloxy)-7-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester, (2E)-
3-Pyridinecarboxylic acid,esters,10-(acetyloxy)-5,7-bis(benzoyloxy)- octahydro-2,2,5a,9-tetramethyl-4-(2-methyl- 1-oxobutoxy)-2H-3,9a-methano-1- benzoxepin-6-yl ester
Butanoic acid,2-methyl-,(3S,4R,5R,5aS,6R,7S,9S,9aS,10R)-6-(acetyloxy)-4,5-bis(benzoyloxy)octahydro-9,10-dihydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-7-ylester
Butanoic acid,(3R,5S,5aR,6R,7S,9R,9aS)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-7-ylester (9CI)
2-Propenoic acid,3-phenyl-,(3R,4S,5S,5aR,6R,7S,9S,9aS,10R)-7-(acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-4,9,10-trihydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6-ylester (9CI)
Butanoic acid,2-methyl-,6,7,10-tris(benzoyloxy)octahydro-4,9-dihydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester (9CI)
2-Propenoic acid,3-phenyl-,(3R,5S,5aS,6R,7S,9R,9aS)-7-(acetyloxy)octahydro-6-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester, (2E)-
2-Propenoic acid,3-phenyl-,(3R,5S,5aR,6R,7S,9R,9aS)-6-(acetyloxy)octahydro-7-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester, (2E)-